Related Experiment Videos
VIP- and PACAP-mediated immunomodulation as prospective therapeutic tools
1Immunology Division, Department of Pathology, Cambridge University, Tennis Court Road, Cambridge CB2 1QP, UK. dp260@mole.bio.cam.ac.uk
Trends in Molecular Medicine
|May 24, 2003
Summary
Vasoactive intestinal peptide (VIP) acts as an anti-inflammatory mediator, similar to T-helper-2 cytokines. This discovery highlights VIP
Area of Science:
- Neuroimmunology
- Molecular Medicine
- Endocrinology
Background:
- The brain and immune system communicate bidirectionally via shared pathways, influencing health and disease.
- Neuropeptides and their receptors are key components of this neuro-immune communication network.
- Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) are structurally related neuropeptides involved in immune system homeostasis.
Purpose of the Study:
- To investigate the role of VIP as a mediator in the neuro-immune axis.
- To explore the potential therapeutic applications of VIP in inflammatory and autoimmune diseases.
Main Methods:
- Utilized murine knockout and transgenic models targeting VIP receptors.
- Examined the molecular mechanisms underlying VIP's function in immune regulation.
Main Results:
- VIP functions as an endogenous anti-inflammatory mediator.
- VIP exhibits characteristics analogous to T-helper-2 (Th2) cytokines.
- VIP plays a role in maintaining immune system balance.
Conclusions:
- VIP is a significant endogenous anti-inflammatory agent within the neuro-immune axis.
- Understanding VIP's molecular mechanisms may lead to novel therapeutic strategies.
- Potential applications include treatments for inflammatory diseases, septic shock, and autoimmune disorders.